Abortion, Induced Clinical Trial
Official title:
Developing and Testing Interventions to Address Use of Conscientious Objection to Deny Women's Access to Abortion Care in Mexico and South Africa
The primary purpose of this research is to develop strategies and interventions to mitigate the impact of conscientious objection on women's access to safe abortion care in Mexico and South Africa using a user-centered design approach and test the feasibility and effectiveness of these interventions.
Conscientious objection (CO) is emerging as a growing barrier to abortion care, and evidence
suggests that it is being incorrectly used as a justification for public sector medical
providers and institutions to exempt themselves from their duties to provide essential
reproductive health services for women. Given this, it is essential to better understand and
address this misuse of CO and find ways to improve women's access to safe abortion services
to prevent them from using unsafe methods which risk their health and lives.
This study will conduct formative research to more fully understand the problem of CO in
Mexico and South Africa and use these findings to develop interventions and strategies to
mitigate the impact of CO on women's access to safe abortion care using a user-centered
design approach. Rapid randomized controlled trials will then be used to assess effectiveness
of the interventions. The specific aims of this study are:
1. Improve our understanding of CO and its impact on access and quality of abortion care
from providers' and facility mangers' perspectives in Mexico, and South Africa.
2. Develop strategies and interventions to mitigate the impact of CO on women's access to
safe abortion care. Using the data collected, a multi-disciplinary Innovation Team will
develop strategies and interventions to respond to the challenges posed by CO using a
user-centered design approach.
3. Rapid-test intervention prototypes. We will test selected strategies (prototypes) in
Mexico, and South Africa with assessments to determine successes, and the feasibility of
scaling up these approaches.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01541293 -
Intrauterine Lidocaine for Laminaria
|
Phase 1 | |
| Completed |
NCT00177333 -
Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens
|
Phase 4 | |
| Completed |
NCT00370487 -
Comparison of the Safety of First Trimester Abortions Performed by Physicians and Non-Physicians in South Africa and Viet Nam.
|
N/A | |
| Completed |
NCT00188071 -
Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen
|
N/A | |
| Completed |
NCT02277249 -
Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
|
N/A | |
| Completed |
NCT00386867 -
A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
|
N/A | |
| Completed |
NCT00677755 -
Medical Abortion for Emergency Contraception Failure
|
N/A | |
| Completed |
NCT02279914 -
Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
|
N/A | |
| Completed |
NCT01597726 -
Cervical Priming Before Dilation & Evacuation
|
N/A | |
| Completed |
NCT01615731 -
Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
|
N/A | |
| Completed |
NCT02318212 -
Dilapan-S / Dilasoft E-Registry in Induced Abortion
|
N/A | |
| Terminated |
NCT00855842 -
Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion
|
N/A | |
| Completed |
NCT00330993 -
Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation
|
Phase 2 | |
| Completed |
NCT00382538 -
Mifepristone and Mid-Trimester Termination of Pregnancy
|
N/A | |
| Completed |
NCT03080493 -
Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT02485444 -
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
|
Phase 4 | |
| Completed |
NCT00969982 -
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
|
N/A | |
| Recruiting |
NCT02480543 -
Different Routes of Misoprostol Prior to First Trimester Surgical Abortion
|
Phase 4 | |
| Completed |
NCT00870272 -
Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)
|
N/A | |
| Completed |
NCT02048098 -
Misoprostol for Second Trimester Termination of Pregnancy
|
Phase 3 |